| Financial Year |
March 31 2023 |
| Monetary Funds |
1,087,133,603.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
43,189,139.00 |
| Accounts Receivable |
161,663,653.76 |
| Advances to Suppliers |
48,803,112.45 |
| Other Receivables |
165,974,640.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
685,025,811.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,104,387.21 |
| Total Current Assets |
2,192,894,347.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,842,037.57 |
| Investment Properties |
48,013,743.28 |
| Fixed Assetes |
2,236,810,617.11 |
| Under-construction Projects |
1,314,813,203.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
147,358,089.05 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,789,796.86 |
| R&D expenses |
-- |
| Goodwill |
35,205,336.45 |
| Long-Term Deferred and Prepaid Expenses |
43,145,257.34 |
| Deferred Income Tax Assets |
80,358,377.02 |
| Other Non-Current Assets |
31,371,014.68 |
| Sub-Total of Non-Current Assets |
4,584,903,535.71 |
| Total Assets |
6,777,797,883.49 |
| Short-Term Loans |
1,524,709,412.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
282,346,001.03 |
| Accounts Received In Advance |
341,503.00 |
| Employee Compensation Payable |
24,191,408.19 |
| Taxes Payable |
7,460,223.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
900,784,132.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
666,907,929.96 |
| Other Current Liabilities |
288,123.14 |
| Sub-Total of Current Liabilities |
3,421,835,046.02 |
| Long-term Loans |
847,818,505.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
111,457,287.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,000,000.00 |
| Deferred Income Tax Liabilities |
9,660,960.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,270,568,734.53 |
| Total Liabilities |
4,692,403,780.55 |
| Paid-In Capital(Or Share Stock) |
806,107,763.00 |
| Capital Surplus |
1,974,537,590.74 |
| Surplus Reserve |
75,495,484.56 |
| LESS:Treasury Stock |
14,205,870.73 |
| Undistributed Profits |
-846,929,488.74 |
| Minority Stockholder's Interest |
52,708,585.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,032,685,517.35 |
| Owner's Equity（Stockholder's Equity） |
2,085,394,102.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,777,797,883.49 |
